Therapeutic strategies targeting Wnt/β‑catenin signaling for colorectal cancer (Review)
- Authors:
- Yong Ji
- Jian Lv
- Di Sun
- Yufeng Huang
-
Affiliations: Department of General Surgery, Jingjiang People's Hospital, Jingjiang, Jiangsu 214500, P.R. China, Department of General Surgery, Jingjiang People's Hospital, Jingjiang, Jiangsu 214500, P.R. China, Department of Oncology, Jingjiang People's Hospital, Jingjiang, Jiangsu 214500, P.R. China - Published online on: October 27, 2021 https://doi.org/10.3892/ijmm.2021.5056
- Article Number: 1
-
Copyright: © Ji et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
This article is mentioned in:
Abstract
|
Tao L, Zhu Y, Gu Y, Zheng J and Yang J: ARHGAP25: A negative regulator of colorectal cancer (CRC) metastasis via the Wnt/beta-catenin pathway. Eur J Pharmacol. 858:1724762019. View Article : Google Scholar |
|
|
Sun X, Xu X and Song L: TKP, a serine protease extracted from Trichosanthes kirilowii, inhibits the migration and invasion of colorectal adenocarcinoma cells by targeting Wnt/β-catenin and Hedgehog/Gli1 signalings. Phytother Res. 34:867–878. 2020. View Article : Google Scholar |
|
|
Xu C, Tian G, Jiang C, Xue H, Kuerbanjiang M, Sun L, Gu L, Zhou H, Liu Y, Zhang Z and Xu Q: NPTX2 promotes colorectal cancer growth and liver metastasis by the activation of the canonical Wnt/β-catenin pathway via FZD6. Cell Death Dis. 10:2172019. View Article : Google Scholar |
|
|
Wang J, Shibayama Y, Zhang A, Ohsaki H, Asano E, Suzuki Y, Kushida Y, Kobara H, Masaki T, Wang Z and Nishiyama A: (Pro)renin receptor promotes colorectal cancer through the Wnt/beta-catenin signaling pathway despite constitutive pathway component mutations. Br J Cancer. 120:229–237. 2019. View Article : Google Scholar |
|
|
Wang W, He Y, Rui J and Xu MQ: MiR-410 acts as an oncogene in colorectal cancer cells by targeting dickkopf-related protein 1 via the Wnt/β-catenin signaling pathway. Oncol Lett. 17:807–814. 2019.PubMed/NCBI |
|
|
Tang Q, Chen J, Di Z, Yuan W, Zhou Z, Liu Z, Han S, Liu Y, Ying G, Shu X and Di M: TM4SF1 promotes EMT and cancer stemness via the Wnt/β-catenin/SOX2 pathway in colorectal cancer. J Exp Clin Cancer Res. 39:2322020. View Article : Google Scholar |
|
|
Lu ML, Zhang Y, Li J, Fu Y, Li WH, Zhao GF, Li XH, Wei L, Liu GB and Huang H: MicroRNA-124 inhibits colorectal cancer cell proliferation and suppresses tumor growth by interacting with PLCB1 and regulating Wnt/β-catenin signaling pathway. Eur Rev Med Pharmacol Sci. 23:121–136. 2019.PubMed/NCBI |
|
|
Shan Z, An N, Qin J, Yang J, Sun H and Yang W: Long non-coding RNA Linc00675 suppresses cell proliferation and metastasis in colorectal cancer via acting on miR-942 and Wnt/β-catenin signaling. Biomed Pharmacother. 101:769–776. 2018. View Article : Google Scholar : PubMed/NCBI |
|
|
Bian J, Dannappel M, Wan C and Firestein R: Transcriptional regulation of Wnt/β-catenin pathway in colorectal cancer. Cells. 9:21252020. View Article : Google Scholar |
|
|
Yuan S, Tao F, Zhang X, Zhang Y, Sun X and Wu D: Role of Wnt/β-catenin signaling in the chemoresistance modulation of colorectal cancer. Biomed Res Int. 2020:93908782020. View Article : Google Scholar |
|
|
Amado NG, Predes D, Moreno MM, Carvalho IO, Mendes FA and Abreu JG: Flavonoids and Wnt/β-catenin signaling: Potential role in colorectal cancer therapies. Int J Mol Sci. 15:12094–12106. 2014. View Article : Google Scholar : PubMed/NCBI |
|
|
Liang G, Fang X, Yang Y and Song Y: Silencing of CEMIP suppresses Wnt/β-catenin/Snail signaling transduction and inhibits EMT program of colorectal cancer cells. Acta Histochem. 20:56–63. 2018. View Article : Google Scholar |
|
|
Yang E, Tacchelly-Benites O, Wang Z, Randall MP, Tian A, Benchabane H, Freemantle S, Pikielny C, Tolwinski NS, Lee E and Ahmed Y: Wnt pathway activation by ADP-ribosylation. Nat Commun. 7:114302016. View Article : Google Scholar : PubMed/NCBI |
|
|
Rennoll S and Yochum G: Regulation of MYC gene expression by aberrant Wnt/β-catenin signaling in colorectal cancer. World J Biol Chem. 6:290–300. 2015. View Article : Google Scholar : PubMed/NCBI |
|
|
Cheng X, Xu X, Chen D, Zhao F and Wang W: Therapeutic potential of targeting the Wnt/β-catenin signaling pathway in colorectal cancer. Biomed Pharmacother. 110:473–481. 2019. View Article : Google Scholar |
|
|
Schuijers J, Mokry M, Hatzis P, Cuppen E and Clevers H: Wnt-induced transcriptional activation is exclusively mediated by TCF/LEF. EMBO J. 33:146–156. 2014. View Article : Google Scholar : PubMed/NCBI |
|
|
Wang S, Yang H, Chen X and Jiang Z: Effects of SOX15 on the colorectal cancer cells via downregulation of the Wnt/β-catenin signaling pathway. Future Oncol. 14:1921–1932. 2018. View Article : Google Scholar : PubMed/NCBI |
|
|
Bernkopf DB, Daum G, Brückner M and Behrens J: Sulforaphane inhibits growth and blocks Wnt/β-catenin signaling of colorectal cancer cells. Oncotarget. 9:33982–33994. 2018. View Article : Google Scholar : PubMed/NCBI |
|
|
Murad LB, da Silva Nogueira P, de Araújo WM, Sousa-Squiavinato ACM, Rocha MR, de Souza WF, de-Freitas-Junior J, Barcellos-de-Souza P, Bastos LG and Morgado-Díaz JA: Docosahexaenoic acid promotes cell cycle arrest and decreases proliferation through WNT/β-catenin modulation in colorectal cancer cells exposed to Y-radiation. Biofactors. 45:24–34. 2019. View Article : Google Scholar |
|
|
Escudero-Paniagua B, Bartolomé RA, Rodríguez S, De Los Ríos V, Pintado L, Jaén M, Lafarga M, Fernández-Aceñero MJ and Casal JI: PAUF/ZG16B promotes colorectal cancer progression through alterations of the mitotic functions and the Wnt/β-catenin pathway. Carcinogenesis. 41:203–213. 2020. |
|
|
Hsu HC, Liu YS, Tseng KC, Tan BC, Chen SJ and Chen HC: LGR5 regulates survival through mitochondria-mediated apoptosis and by targeting the Wnt/β-catenin signaling pathway in colorectal cancer cells. Cell Signal. 26:2333–2342. 2014. View Article : Google Scholar : PubMed/NCBI |
|
|
He TC, Sparks AB, Rago C, Hermeking H, Zawel L, Da Costa LT, Morin PJ, Vogelstein B and Kinzler KW: Identification of c-MYC as a target of the APC pathway. Science. 281:1509–1512. 1998. View Article : Google Scholar : PubMed/NCBI |
|
|
Tetsu O and McCormick F: Beta-catenin regulates expression of cyclin D1 in coloncarcinoma cells. Nature. 398:422–426. 1999. View Article : Google Scholar : PubMed/NCBI |
|
|
Brabletz T, Jung A, Dag S, Hlubek F and Kirchner T: Beta-catenin regulates the expression of the matrix metalloproteinase-7 in human colorectal cancer. Am J Pathol. 155:1033–1038. 1999. View Article : Google Scholar : PubMed/NCBI |
|
|
Zhang X, Xiong Y, Tang F, Bian Y, Chen Y and Zhang F: Long noncoding RNA HNF1A-AS1 indicates a poor prognosis of colorectal cancer and promotes carcinogenesis via activation of the Wnt/β-catenin signaling pathway. Biomed Pharmacother. 96:877–883. 2017. View Article : Google Scholar : PubMed/NCBI |
|
|
Baldus SE, Monig SP, Huxel S, Landsberg S, Hanisch FG, Engelmann K, Schneider PM, Thiele J, Holscher AH and Dienes HP: MUC1 and nuclear beta-catenin are coexpressed at the invasion front of colorectal carcinomas and are both correlated with tumor prognosis. Clin Cancer Res. 10:2790–2796. 2004. View Article : Google Scholar : PubMed/NCBI |
|
|
Bordonaro M and Lazarova DL: CREB-binding protein, p300, butyrate, and Wnt signaling in colorectal cancer. World J Gastroenterol. 21:8238–8248. 2015. View Article : Google Scholar : PubMed/NCBI |
|
|
Lazarova DL, Chiaro C, Wong T, Drago E, Rainey A, O'Malley S and Bordonaro M: CBP activity mediates effects of the histone deacetylase inhibitor butyrate on WNT activity and apoptosis in colon cancer cells. J Cancer. 4:481–490. 2013. View Article : Google Scholar : PubMed/NCBI |
|
|
Giles RH, van Es JH and Clevers H: Caught up in a Wnt storm: Wnt signaling in cancer. Biochim Biophys Acta. 1653:1–24. 2003.PubMed/NCBI |
|
|
Farkas SA, Vymetalkova V, Vodickova L, Vodicka P and Nilsson TK: DNA methylation changes in genes frequently mutated in sporadic colorectal cancer and in the DNA repair and Wnt/β-catenin signaling pathway genes. Epigenomics. 6:179–191. 2014. View Article : Google Scholar : PubMed/NCBI |
|
|
Yang D, Li Q, Shang R, Yao L, Wu L, Zhang M, Zhang L, Xu M, Lu Z, Zhou J, et al: WNT4 secreted by tumor tissues promotes tumor progression in colorectal cancer by activation of the Wnt/β-catenin signalling pathway. J Exp Clin Cancer Res. 39:2512020. View Article : Google Scholar |
|
|
Prossomariti A, Piazzi G, Alquati C and Ricciardiello L: Are Wnt/β-catenin and PI3K/AKT/mTORC1 distinct pathways in colorectal cancer? Cell Mol Gastroenterol Hepatol. 10:491–506. 2020. View Article : Google Scholar : |
|
|
Li W, Yang CJ, Wang LQ, Wu J, Dai C, Yuan YM, Li GQ and Yao MC: A tannin compound from Sanguisorba officinalis blocks Wnt/β-catenin signaling pathway and induces apoptosis of colorectal cancer cells. Chin Med. 14:222019. View Article : Google Scholar |
|
|
Duval A, Rolland S, Tubacher E, Bui H, Thomas G and Hamelin R: The human T-cell transcription factor-4 gene: Structure, extensive characterization of alternative splicings, and mutational analysis in colorectal cancer cell lines. Cancer Res. 60:3872–3879. 2000.PubMed/NCBI |
|
|
Wu Y, Fang G, Wang X, Wang H, Chen W, Li L, Ye T, Gong L, Ke C and Cai Y: NUP153 overexpression suppresses the proliferation of colorectal cancer by negatively regulating Wnt/β-catenin signaling pathway and predicts good prognosis. Cancer Biomark. 24:61–70. 2019. View Article : Google Scholar |
|
|
Tang Q, Zou Z, Zou C, Zhang Q, Huang R, Guan X, Li Q, Han Z, Wang D, Wei H, et al: MicroRNA-93 suppress colorectal cancer development via Wnt/β-catenin pathway downregulating. Tumour Biol. 36:1701–1710. 2015. View Article : Google Scholar |
|
|
Ye Q, Yao G, Zhang M, Guo G, Hu Y, Jiang J, Cheng L, Shi J, Li H, Zhang Y and Liu H: A novel ent-kaurane diterpenoid executes antitumor function in colorectal cancer cells by inhibiting Wnt/β-catenin signaling. Carcinogenesis. 36:318–326. 2015. View Article : Google Scholar : PubMed/NCBI |
|
|
Jin LH, Shao QJ, Luo W, Ye ZY, Li Q and Lin SC: Detection of point mutations of the Axin1 gene in colorectal cancers. Int J Cancer. 107:696–699. 2003. View Article : Google Scholar : PubMed/NCBI |
|
|
Humphries A and Wright NA: Colonic crypt organization and tumorigenesis. Nat Rev Cancer. 8:415–424. 2008. View Article : Google Scholar : PubMed/NCBI |
|
|
Cancer Genome Atlas Network: Comprehensive molecular characterization of human colon and rectal cancer. Nature. 487:330–337. 2012. View Article : Google Scholar : PubMed/NCBI |
|
|
Chen HY, Lang YD, Lin HN, Liu YR, Liao CC, Nana AW, Yen Y and Chen RH: MiR-103/107 prolong Wnt/β-catenin signaling and colorectal cancer stemness by targeting Axin2. Sci Rep. 9:96872019. View Article : Google Scholar |
|
|
Sun Y, Lai X, Yu Y, Li J, Cao L, Lin W, Huang C, Liao J, Chen W, Li C, et al: Inhibitor of DNA binding 1 (Id1) mediates stemness of colorectal cancer cells through the Id1-c-Myc-PLAC8 axis via the Wnt/β-catenin and Shh signaling pathways. Cancer Manag Res. 11:6855–6869. 2019. View Article : Google Scholar : |
|
|
Ayinde O, Wang Z, Pinton G, Moro L and Griffin M: Transglutaminase 2 maintains a colorectal cancer stem phenotype by regulating epithelial-mesenchymal transition. Oncotarget. 10:4556–4569. 2019. View Article : Google Scholar : PubMed/NCBI |
|
|
Chen Y, Li Y, Wang XQ, Meng Y, Zhang Q, Zhu JY, Chen JQ, Cao WS, Wang XQ, Xie CF, et al: Phenethyl isothiocyanate inhibits colorectal cancer stem cells by suppressing Wnt/β-catenin pathway. Phytother Res. 32:2447–2455. 2018. View Article : Google Scholar : PubMed/NCBI |
|
|
Chi J, Zhang H, Hu J, Song Y, Li J, Wang L and Wang Z: AGR3 promotes the stemness of colorectal cancer via modulating Wnt/β-catenin signalling. Cell Signal. 65:1094192020. View Article : Google Scholar |
|
|
Wang P, Gao XY, Yang SQ, Sun ZX, Dian LL, Qasim M, Phyo AT, Liang ZS and Sun YF: Jatrorrhizine inhibits colorectal carcinoma proliferation and metastasis through Wnt/β-catenin signaling pathway and epithelial-mesenchymal transition. Drug Des Devel Ther. 13:2235–2247. 2019. View Article : Google Scholar : |
|
|
Cho YH, Ro EJ, Yoon JS, Mizutani T, Kang DW, Park JC, Il Kim T, Clevers H and Choi KY: 5-FU promotes stemness of colorectal cancer via p53-mediated WNT/β-catenin pathway activation. Nat Commun. 11:53212020. View Article : Google Scholar |
|
|
Chen S, Song X, Chen Z, Li X, Li M, Liu H and Li J: CD133 expression and the prognosis of colorectal cancer: A systematic review and meta-analysis. PLoS One. 8:e563802013. View Article : Google Scholar : PubMed/NCBI |
|
|
Zhang Q, Li XT, Chen Y, Chen JQ, Zhu JY, Meng Y, Wang XQ, Li Y, Geng SS, Xie CF, et al: Wnt/beta-catenin signaling mediates the suppressive effects of diallyl trisulfide on colorectal cancer stem cells. Cancer Chemother Pharmacol. 81:969–977. 2018. View Article : Google Scholar : PubMed/NCBI |
|
|
Dahal Lamichane B, Jung SY, Yun J, Kang S, Kim DY, Lamichane S, Kim YJ, Park JH, Jang WB, Ji ST, et al: AGR2 is a target of canonical Wnt/β-catenin signaling and is important for stemness maintenance in colorectal cancer stem cells. Biochem Biophys Res Commun. 515:600–606. 2019. View Article : Google Scholar : PubMed/NCBI |
|
|
Yang AD, Fan F, Camp ER, ven Buren G, Liu W, Somcio R, Gray MJ, Cheng H, Hoff PM and Ellis LM: Chronic oxaliplatin resistance induces epithelial-to-mesenchymal transition in colorectal cancer cell lines. Clin Cancer Res. 12(14 Pt 1): 4147–4153. 2006. View Article : Google Scholar : PubMed/NCBI |
|
|
Zhao H, Zhao C, Li H, Zhang D and Liu G: E2A attenuates tumor-initiating capacity of colorectal cancer cells via the Wnt/beta-catenin pathway. J Exp Clin Cancer Res. 38:2762019. View Article : Google Scholar : PubMed/NCBI |
|
|
Ma CT, Luo HS, Gao F, Tang QC and Chen W: Fusobacterium nucleatum promotes the progression of colorectal cancer by interacting with E-cadherin. Oncol Lett. 16:2606–2612. 2018.PubMed/NCBI |
|
|
Ghahhari NM and Babashah S: Interplay between microRNAs and WNT/β-catenin signalling pathway regulates epithelial-mesenchymal transition in cancer. Eur J Cancer. 51:1638–1649. 2015. View Article : Google Scholar : PubMed/NCBI |
|
|
Yuan Z, Yu X, Ni B, Chen D, Yang Z, Huang J, Wang J, Chen D and Wang L: Overexpression of long non-coding RNA-CTD903 inhibits colorectal cancer invasion and migration by repressing Wnt/β-catenin signaling and predicts favorable prognosis. Int J Oncol. 48:2675–2685. 2016. View Article : Google Scholar : PubMed/NCBI |
|
|
Qi J, Yu Y, Akilli Öztürk Ö, Holland JD, Besser D, Fritzmann J, Wulf-Goldenberg A, Eckert K, Fichtner I and Birchmeier W: New Wnt/β-catenin target genes promote experimental metastasis and migration of colorectal cancer cells through different signals. Gut. 65:1690–1701. 2016. View Article : Google Scholar |
|
|
Gu Y, Wang Q, Guo K, Qin W, Liao W, Wang S, Ding Y and Lin J: TUSC3 promotes colorectal cancer progression and epithelial-mesenchymal transition (EMT) through WNT/β-catenin and MAPK signalling. J Pathol. 239:60–71. 2016. View Article : Google Scholar : PubMed/NCBI |
|
|
Yuan H, Wei R, Xiao Y, Song Y, Wang J, Yu H, Fang T, Xu W and Mao S: RHBDF1 regulates APC-mediated stimulation of the epithelial-to-mesenchymal transition and proliferation of colorectal cancer cells in part via the Wnt/β-catenin signalling pathway. Exp Cell Res. 368:24–36. 2018. View Article : Google Scholar : PubMed/NCBI |
|
|
Ren Y, Tao J, Jiang Z, Guo D and Tang J: Pimozide suppresses colorectal cancer via inhibition of Wnt/β-catenin signaling pathway. Life Sci. 209:267–273. 2018. View Article : Google Scholar : PubMed/NCBI |
|
|
Yuan X, Sun X, Shi X, Wang H, Wu G, Jiang C, Yu D, Zhang W, Xue B and Ding Y: USP39 promotes colorectal cancer growth and metastasis through the Wnt/β-catenin pathway. Oncol Rep. 37:2398–2404. 2017. View Article : Google Scholar : PubMed/NCBI |
|
|
Slack FJ and Chinnaiyan AM: The role of Non-coding RNAs in oncology. Cell. 179:1033–1055. 2019. View Article : Google Scholar : PubMed/NCBI |
|
|
Zhang Z, Zhou C, Chang Y, Zhang Z, Hu Y, Zhang F, Lu Y, Zheng L, Zhang W and Li X and Li X: Long non-coding RNA CASC11 interacts with hnRNP-K and activates the WNT/β-catenin pathway to promote growth and metastasis in colorectal cancer. Cancer Lett. 376:62–73. 2016. View Article : Google Scholar : PubMed/NCBI |
|
|
Ye Y, Gu B, Wang Y, Shen S and Huang W: YY1-induced upregulation of long noncoding RNA ARAP1-AS1 promotes cell migration and invasion in colorectal cancer through the Wnt/β-catenin signaling pathway. Cancer Biother Radiopharm. 34:519–528. 2019. View Article : Google Scholar : PubMed/NCBI |
|
|
Liao T, Maierdan SL and Lv C: ROR1-AS1 promotes tumorigenesis of colorectal cancer via targeting Wnt/β-catenin. Eur Rev Med Pharmacol Sci. 24:75612020. |
|
|
Wang X, Zhou J, Xu M, Yan Y, Huang L, Kuang Y, Liu Y, Li P, Zheng W, Liu H and Jia B: A 15-lncRNA signature predicts survival and functions as a ceRNA in patients with colorectal cancer. Cancer Manag Res. 10:5799–5806. 2018. View Article : Google Scholar : PubMed/NCBI |
|
|
Li S, Wu T, Zhang D, Sun X and Zhang X: The long non-coding RNA HCG18 promotes the growth and invasion of colorectal cancer cells through sponging miR-1271 and upregulating MTDH/Wnt/β-catenin. Clin Exp Pharmacol Physiol. 47:703–712. 2020. View Article : Google Scholar |
|
|
Sun LB, Zhao SF, Zhu JJ, Han Y and Shan TD: Long noncoding RNA UCID sponges miR-152-3p to promote colorectal cancer cell migration and invasion via the Wnt/β-catenin signaling pathway. Oncol Rep. 44:1194–1205. 2020. View Article : Google Scholar : PubMed/NCBI |
|
|
Jin YD, Ren YR, Gao YX, Zhang L and Ding Z: Hsa_ circ_0005075 predicts a poor prognosis and acts as an oncogene in colorectal cancer via activating Wnt/β-catenin pathway. Eur Rev Med Pharmacol Sci. 23:3311–3319. 2019.PubMed/NCBI |
|
|
Chen B, Zhang D, Kuai J, Cheng M, Fang X and Li G: Upregulation of miR-199a/b contributes to cisplatin resistance via Wnt/β-catenin-ABCG2 signaling pathway in ALDHA1+ colorectal cancer stem cells. Tumour Biol. 39:10104283177151552017. |
|
|
Wan YC, Li T, Han YD, Zhang HY, Lin H and Zhang B: MicroRNA-155 enhances the activation of Wnt/β-catenin signaling in colorectal carcinoma by suppressing HMG-box transcription factor 1. Mol Med Rep. 13:2221–2228. 2016. View Article : Google Scholar : PubMed/NCBI |
|
|
Li Q, Lai Q, He C, Fang Y, Yan Q, Zhang Y, Wang X, Gu C, Wang Y, Ye L, et al: RUNX1 promotes tumour metastasis by activating the Wnt/β-catenin signaling pathway and EMT in colorectal cancer. J Exp Clin Cancer Res. 38:3342019. View Article : Google Scholar |
|
|
Li J, He M, Xu W and Huang S: LINC01354 interacting with hnRNP-D contributes to the proliferation and metastasis in colorectal cancer through activating Wnt/β-catenin signaling pathway. J Exp Clin Cancer Res. 38:1612019. View Article : Google Scholar |
|
|
Qi H, Wang J, Wang F and Ma H: Long non-coding RNA SNHG1 promotes cell proliferation and tumorigenesis in colorectal cancer via Wnt/β-catenin signaling. Pharmazie. 72:395–401. 2017. |
|
|
Liu R, Deng P, Zhang Y, Wang Y and Peng C: Circ_0082182 promotes oncogenesis and metastasis of colorectal cancer in vitro and in vivo by sponging miR-411 and miR-1205 to activate the Wnt/β-catenin pathway. World J Surg Oncol. 19:512021. View Article : Google Scholar |
|
|
Fang Q, Yang A, Dong A and Zhao L: circPDSS1 stimulates the development of colorectal cancer via activating the Wnt/β-catenin signaling. Onco Targets Ther. 13:6329–6337. 2020. View Article : Google Scholar : |
|
|
Zheng K, Zhou X, Yu J, Li Q, Wang H, Li M, Shao Z, Zhang F, Luo Y, Shen Z, et al: Epigenetic silencing of miR-490-3p promotes development of an aggressive colorectal cancer phenotype through activation of the Wnt/β-catenin signaling pathway. Cancer Lett. 376:178–187. 2016. View Article : Google Scholar : PubMed/NCBI |
|
|
Gu C, Cai J, Xu Z, Zhou S, Ye L, Yan Q, Zhang Y, Fang Y, Liu Y, Tu C, et al: MiR-532-3p suppresses colorectal cancer progression by disrupting the ETS1/TGM2 axis-mediated Wnt/β-catenin signaling. Cell Death Dis. 10:7392019. View Article : Google Scholar |
|
|
Yu FB, Sheng J, Yu JM, Liu JH, Qin XX and Mou B: MiR-19a-3p regulates the Forkhead box F2-mediated Wnt/β-catenin signaling pathway and affects the biological functions of colorectal cancer cells. World J Gastroenterol. 26:627–644. 2020. View Article : Google Scholar : PubMed/NCBI |
|
|
Wu J, Chen Z, Liu W, Zhang Y, Feng W, Yuan Y, Ye J, Wang L, Cai S, He Y, et al: MicroRNA-188-5p targeting Forkhead Box L1 promotes colorectal cancer progression via activating Wnt/β-catenin signaling. Oncol Res. Nov 23–2020.Epub ahead of print. View Article : Google Scholar |
|
|
Huang L, Liu Z, Hu J, Luo Z, Zhang C, Wang L and Wang Z: MiR-377-3p suppresses colorectal cancer through negative regulation on Wnt/β-catenin signaling by targeting XIAP and ZEB2. Pharmacol Res. 156:1047742020. View Article : Google Scholar |
|
|
Sun N, Zhang L, Zhang C and Yuan Y: MiR-144-3p inhibits cell proliferation of colorectal cancer cells by targeting BCL6 via inhibition of Wnt/β-catenin signaling. Cell Mol Biol Lett. 25:192020. View Article : Google Scholar |
|
|
Luo Y, Chen JJ, Lv Q, Qin J, Huang YZ, Yu MH and Zhong M: Long non-coding RNA NEAT1 promotes colorectal cancer progression by competitively binding miR-34a with SIRT1 and enhancing the Wnt/β-catenin signaling pathway. Cancer Lett. 441:11–22. 2019. View Article : Google Scholar |
|
|
Wang G, Li Z, Zhao Q, Zhu Y, Zhao C, Li X, Ma Z, Li X and Zhang Y: LincRNA-p21 enhances the sensitivity of radiotherapy for human colorectal cancer by targeting the Wnt/β-catenin signaling pathway. Oncol Rep. 31:1839–1845. 2014. View Article : Google Scholar : PubMed/NCBI |
|
|
Ma Y, Yang Y, Wang F, Moyer MP, Wei Q, Zhang P, Yang Z, Liu W, Zhang H, Chen N, et al: Long non-coding RNA CCAL regulates colorectal cancer progression by activating Wnt/β-catenin signaling pathway via suppression of activator protein 2α. Gut. 65:1494–1504. 2016. View Article : Google Scholar |
|
|
Wu KF, Liang WC, Feng L, Pang JX, Waye MM, Zhang JF and Fu WM: H19 mediates methotrexate resistance in colorectal cancer through activating Wnt/β-catenin pathway. Exp Cell Res. 350:312–317. 2017. View Article : Google Scholar |
|
|
Zhou T, Wu L, Ma N, Tang F, Zong Z and Chen S: LncRNA PART1 regulates colorectal cancer via targeting miR-150-5p/miR-520h/CTNNB1 and activating Wnt/β-catenin pathway. Int J Biochem Cell Biol. 118:1056372020. View Article : Google Scholar |
|
|
Song J, Shu H, Zhang L and Xiong J: Long noncoding RNA GAS5 inhibits angiogenesis and metastasis of colorectal cancer through the Wnt/β-catenin signaling pathway. J Cell Biochem. Jan 22–2019.Epub ahead of print. |
|
|
Zhu Y, Bian Y, Zhang Q, Hu J, Li L, Yang M, Qian H, Yu L, Liu B and Qian X: LINC00365 promotes colorectal cancer cell progression through the Wnt/β-catenin signaling pathway. J Cell Biochem. 121:1260–1272. 2020. View Article : Google Scholar |
|
|
Liu Z, Gu Y, Cheng X, Jiang H, Huang Y, Zhang Y, Yu G, Cheng Y and Zhou L: Upregulation lnc-NEAT1 contributes to colorectal cancer progression through sponging miR-486-5p and activating NR4A1/Wnt/β-catenin pathway. Cancer Biomark. 30:309–319. 2021. View Article : Google Scholar |
|
|
Duan W, Kong X, Li J, Li P, Zhao Y, Liu T, Binang HB, Wang Y, Du L and Wang C: LncRNA AC010789.1 promotes colorectal cancer progression by targeting MicroRNA-432-3p/ZEB1 axis and the Wnt/β-catenin signaling pathway. Front Cell Dev Biol. 8:5653552020. View Article : Google Scholar |
|
|
Tang X, Sun G, He Q, Wang C, Shi J, Gao L, Ye J, Liang Y and Qu H: Circular noncoding RNA circMBOAT2 is a novel tumor marker and regulates proliferation/migration by sponging miR-519d-3p in colorectal cancer. Cell Death Dis. 11:6252020. View Article : Google Scholar : PubMed/NCBI |
|
|
Chen H, Pei L, Xie P and Guo G: Circ-PRKDC contributes to 5-Fluorouracil resistance of colorectal cancer cells by regulating miR-375/FOXM1 Axis and Wnt/β-catenin pathway. Onco Targets Ther. 13:5939–5953. 2020. View Article : Google Scholar : |
|
|
Fang G, Ye BL, Hu BR, Ruan XJ and Shi YX: CircRNA_100290 promotes colorectal cancer progression through miR-516b-induced downregulation of FZD4 expression and Wnt/β-catenin signaling. Biochem Biophys Res Commun. 504:184–189. 2018. View Article : Google Scholar : PubMed/NCBI |
|
|
Ge Z, Li LF, Wang CY, Wang Y and Ma WL: CircMTO1 inhibits cell proliferation and invasion by regulating Wnt/β-catenin signaling pathway in colorectal cancer. Eur Rev Med Pharmacol Sci. 22:8203–8209. 2018.PubMed/NCBI |
|
|
Li JW, Huang CZ, Li JH, Yuan JH, Chen QH, Zhang WF, Xu ZS, Liu YP, Li Y, Zhan MX and Lu LG: Knockdown of metadherin inhibits cell proliferation and migration in colorectal cancer. Oncol Rep. 40:2215–2223. 2018.PubMed/NCBI |
|
|
Huang G, Wu X, Li S, Xu X, Zhu H and Chen X: The long noncoding RNA CASC2 functions as a competing endogenous RNA by sponging miR-18a in colorectal cancer. Sci Rep. 6:265242016. View Article : Google Scholar : PubMed/NCBI |
|
|
Zeng K, Chen X, Xu M, Liu X, Hu X, Xu T, Sun H, Pan Y, He B and Wang S: CircHIPK3 promotes colorectal cancer growth and metastasis by sponging miR-7. Cell Death Dis. 9:4172018. View Article : Google Scholar : PubMed/NCBI |
|
|
Pálmer HG, González-Sancho JM, Espada J, Berciano MT, Puig I, Baulida J, Quintanilla M, Cano A, de Herreros AG, Lafarga M and Muñoz A: Vitamin D(3) promotes the differentiation of colon carcinoma cells by the induction of E-cadherin and the inhibition of beta-catenin signaling. J Cell Biol. 154:369–387. 2001. View Article : Google Scholar : PubMed/NCBI |
|
|
Sadot E, Simcha I, Shtuman M, Ben-Ze'ev A and Geiger B: Inhibition of beta-catenin-mediated transactivation by cadherin derivatives. Proc Natl Acad Sci USA. 95:15339–15344. 1998. View Article : Google Scholar : PubMed/NCBI |
|
|
Orsulic S, Huber O, Aberle H, Arnold S and Kemler R: E-cadherin binding prevents beta-catenin nuclear localization and beta-catenin/LEF-1-mediated transactivation. J Cell Sci. 112(Pt 8): 12451999. View Article : Google Scholar |
|
|
Shahi S, Ang CS and Mathivanan S: A high-resolution mass spectrometry-based quantitative metabolomic workflow high-lights defects in 5-fluorouracil metabolism in cancer cells with acquired chemoresistance. Biology (Basel). 9:962020. |
|
|
Urushibara S, Tsubota T, Asai R, Azumi J, Ashida K, Fujiwara Y and Shiota G: WNT/β-Catenin Signaling Inhibitor IC-2 Suppresses Sphere Formation and Sensitizes Colorectal Cancer Cells to 5-Fluorouracil. Anticancer Res. 37:4085–4091. 2017.PubMed/NCBI |
|
|
Emami KH, Nguyen C, Ma H, Kim DH, Jeong KW, Eguchi M, Moon RT, Teo JL, Kim HY, Moon SH, et al: A small molecule inhibitor of beta-catenin/CREB-binding protein transcription [corrected]. Proc Natl Acad Sci USA. 101:12682–12687. 2004. View Article : Google Scholar |
|
|
Ma H, Nguyen C, Lee KS and Kahn M: Differential roles for the coactivators CBP and p300 on TCF/beta-catenin-mediated survivin gene expression. Oncogene. 24:3619–3631. 2005. View Article : Google Scholar : PubMed/NCBI |
|
|
Xing J, Cao G and Fu C: HMGA1 interacts with β-catenin to positively regulate Wnt/β-catenin signaling in colorectal cancer cells. Pathol Oncol Res. 20:847–851. 2014. View Article : Google Scholar : PubMed/NCBI |
|
|
Tian S, Hu J, Tao K, Wang J, Chu Y, Li J, Liu Z, Ding X, Xu L, Li Q, et al: Secreted AGR2 promotes invasion of colorectal cancer cells via Wnt 11-mediated non-canonical Wnt signaling. Exp Cell Res. 364:198–207. 2018. View Article : Google Scholar : PubMed/NCBI |
|
|
Zhao ZR, Zhang ZY, Zhang H, Jiang L, Wang MW and Sun XF: Overexpression of Id-1 protein is a marker in colorectal cancer progression. Oncol Rep. 19:419–424. 2008.PubMed/NCBI |
|
|
Cheng H, Sun X, Li J, He P, Liu W and Meng X: Knockdown of Uba2 inhibits colorectal cancer cell invasion and migration through downregulation of the Wnt/beta-catenin signaling pathway. J Cell Biochem. 119:6914–6925. 2018. View Article : Google Scholar : PubMed/NCBI |
|
|
Hu TH, Yao Y, Yu S, Han LL, Wang WJ, Guo H, Tian T, Ruan ZP, Kang XM, Wang J, et al: SDF-1/CXCR4 promotes epithelial-mesenchymal transition and progression of colorectal cancer by activation of the Wnt/β-catenin signaling pathway. Cancer Lett. 354:417–426. 2014. View Article : Google Scholar : PubMed/NCBI |
|
|
Yang Y, Zhao Y, Hu N, Zhao J and Bai Y: lncRNA KIAA0125 functions as a tumor suppressor modulating growth and metastasis of colorectal cancer via Wnt/β-catenin pathway. Cell Biol Int. 43:1463–1470. 2019. View Article : Google Scholar : |
|
|
Matsuo J, Haga S, Hashimoto K, Okubo T, Ozawa T, Ozaki M and Yamaguchi H: Activation of caspase-3 during Chlamydia trachomatis-induced apoptosis at a late stage. Can J Microbiol. 65:135–143. 2019. View Article : Google Scholar |
|
|
Lenz HJ and Kahn M: Safely targeting cancer stem cells via selective catenin coactivator antagonism. Cancer Sci. 105:1087–1092. 2014. View Article : Google Scholar : PubMed/NCBI |
|
|
Hague A, Elder DJ, Hicks DJ and Paraskeva C: Apoptosis in colorectal tumour cells: Induction by the short chain fatty acids butyrate, propionate and acetate and by the bile salt deoxycholate. Int J Cancer. 60:400–406. 1995. View Article : Google Scholar : PubMed/NCBI |
|
|
Bingham SA, Day NE, Luben R, Ferrari P, Slimani N, Norat T, Clavel-Chapelon F, Kesse E, Nieters A, Boeing H, et al: Dietary fibre in food and protection against colorectal cancer in the European prospective investigation into cancer and nutrition (EPIC): An observational study. Lancet. 361:1496–1501. 2003. View Article : Google Scholar : PubMed/NCBI |
|
|
Lazarova DL, Bordonaro M, Carbone R and Sartorelli AC: Linear relationship between Wnt activity levels and apoptosis in colorectal carcinoma cells exposed to butyrate. Int J Cancer. 110:523–531. 2004. View Article : Google Scholar : PubMed/NCBI |
|
|
Lazarova DL, Wong T, Chiaro C, Drago E and Bordonaro M: p300 influences butyrate-mediated WNT hyperactivation in colorectal cancer cells. J Cancer. 4:491–501. 2013. View Article : Google Scholar : PubMed/NCBI |
|
|
Lazarova D, Lee A, Wong T, Marian B, Chiaro C, Rainey C and Bordonaro M: Modulation of Wnt activity and cell physiology by butyrate in lt97 microadenoma cells. J Cancer. 5:203–213. 2014. View Article : Google Scholar : PubMed/NCBI |
|
|
Medina V, Edmonds B, Young GP, James R, Appleton S and Zalewski PD: Induction of caspase-3 protease activity and apoptosis by butyrate and trichostatin A (inhibitors of histone deacetylase): Dependence on protein synthesis and synergy with a mitochondrial/cytochrome c-dependent pathway. Cancer Res. 57:3697–3707. 1997.PubMed/NCBI |
|
|
Bordonaro M, Lazarova DL and Sartorelli AC: The activation of beta-catenin by Wnt signaling mediates the effects of histone deacetylase inhibitors. Exp Cell Res. 313:1652–1666. 2007. View Article : Google Scholar : PubMed/NCBI |
|
|
Yang P, Yu D, Zhou J, Zhuang S and Jiang T: TGM2 interference regulates the angiogenesis and apoptosis of colorectal cancer via Wnt/β-catenin pathway. Cell Cycle. 18:1122–1134. 2019. View Article : Google Scholar : PubMed/NCBI |
|
|
Azevedo Martins JM, Rabelo-Santos SH, do Amaral Westin MC and Zeferino LC: Tumoral and stromal expression of MMP-2, MMP-9, MMP-14, TIMP-1, TIMP-2, and VEGF-A in cervical cancer patient survival: A competing risk analysis. BMC Cancer. 20:6602020. View Article : Google Scholar : PubMed/NCBI |
|
|
Surh YJ: Cancer chemoprevention with dietary phytochemicals. Nat Rev Cancer. 3:768–780. 2003. View Article : Google Scholar : PubMed/NCBI |
|
|
Amado NG, Fonseca BF, Cerqueira DM, Reis AH, Simas AB, Kuster RM, Mendes FA and Abreu JG: Effects of natural compounds on xenopus embryogenesis: A potential read out for functional drug discovery targeting Wnt/β-catenin signaling. Curr Top Med Chem. 12:2103–2113. 2012. View Article : Google Scholar |
|
|
Sun H, Jiang C, Cong L, Wu N, Wang X, Hao M, Liu T, Wang L, Liu Y and Cong X: CYP24A1 inhibition facilitates the antiproliferative effect of 1,25(OH)2D3 through downregulation of the WNT/β-catenin pathway and methylation-mediated regulation of CYP24A1 in colorectal cancer cells. DNA Cell Biol. 37:742–749. 2018. View Article : Google Scholar : PubMed/NCBI |
|
|
Park CH, Chang JY, Hahm ER, Park S, Kim HK and Yang CH: Quercetin, a potent inhibitor against beta-catenin/Tcf signaling in SW480 colon cancer cells. Biochem Biophys Res Commun. 328:227–234. 2005. View Article : Google Scholar : PubMed/NCBI |
|
|
Pahlke G, Ngiewih Y, Kern M, Jakobs S, Marko D and Eisenbrand G: Impact of quercetin and EGCG on key elements of the Wnt pathway in human colon carcinoma cells. J Agric Food Chem. 54:7075–7082. 2006. View Article : Google Scholar : PubMed/NCBI |
|
|
Ju J, Hong J, Zhou JN, Pan Z, Bose M, Liao J, Yang GY, Liu YY, Hou Z, Lin Y, et al: Inhibition of intestinal tumorigenesis in Apcmin/+ mice by (-)-epigallocatechin-3-gallate, the major catechin in green tea. Cancer Res. 65:10623–10631. 2005. View Article : Google Scholar : PubMed/NCBI |
|
|
Bose M, Hao X, Ju J, Husain A, Park S, Lambert JD and Yang CS: Inhibition of tumorigenesis in ApcMin/+ mice by a combination of (-)-epigallocatechin-3-gallate and fish oil. J Agric Food Chem. 55:7695–7700. 2007. View Article : Google Scholar : PubMed/NCBI |
|
|
Kaur M, Velmurugan B, Tyagi A, Agarwal C, Singh RP and Agarwal R: Silibinin suppresses growth of human colorectal carcinoma SW480 cells in culture and xenograft through down-regulation of beta-catenin-dependent signaling. Neoplasia. 12:415–424. 2010. View Article : Google Scholar : PubMed/NCBI |
|
|
He L, Lu N, Dai Q, Zhao Y, Zhao L, Wang H, Li Z, You Q and Guo Q: Wogonin induced G1 cell cycle arrest by regulating Wnt/β-catenin signaling pathway and inactivating CDK8 in human colorectal cancer carcinoma cells. Toxicology. 312:36–47. 2013. View Article : Google Scholar : PubMed/NCBI |
|
|
Predes D, Oliveira LFS, Ferreira LSS, Maia LA, Delou JMA, Faletti A, Oliveira I, Amado NG, Reis AH, Fraga CAM, et al: The chalcone lonchocarpin inhibits Wnt/β-catenin signaling and suppresses colorectal cancer proliferation. Cancers (Basel). 11:19682019. View Article : Google Scholar |
|
|
Bastos LG, de Marcondes PG, de-Freitas-Junior JC, Leve F, Mencalha AL, de Souza WF, de Araujo WM, Tanaka MN, Abdelhay ES and Morgado-Díaz JA: Progeny from irradiated colorectal cancer cells acquire an EMT-like phenotype and activate Wnt/β-catenin pathway. J Cell Biochem. 115:2175–2187. 2014. View Article : Google Scholar : PubMed/NCBI |
|
|
Jang E, Inn KS, Jang YP, Lee KT and Lee JH: Phytotherapeutic activities of sanguisorba officinalis and its chemical constituents: A review. Am J Chin Med. 46:299–318. 2018. View Article : Google Scholar : PubMed/NCBI |
|
|
Liu MP, Li W, Dai C, Lam CWK, Li Z, Chen JF, Chen ZG, Zhang W and Yao MC: Aqueous extract of Sanguisorba officinalis blocks the Wnt/β-catenin signaling pathway in colorectal cancer cells. Rsc Adv. 8:10197–10206. 2018. View Article : Google Scholar |
|
|
Kang YJ, Park HJ, Chung HJ, Min HY, Park EJ, Lee MA, Shin Y and Lee SK: Wnt/β-catenin signaling mediates the antitumor activity of magnolol in colorectal cancer cells. Mol Pharmacol. 82:168–177. 2012. View Article : Google Scholar : PubMed/NCBI |
|
|
Wei LH, Lin JM, Chu JF, Chen HW, Li QY and Peng J: Scutellaria barbata D. Don inhibits colorectal cancer growth via suppression of Wnt/β-catenin signaling pathway. Chin J Integr Med. 23:858–863. 2017. View Article : Google Scholar : PubMed/NCBI |
|
|
Zhao Q, Bi Y, Zhong J, Ren Z, Liu Y, Jia J, Yu M, Tan Y, Zhang Q and Yu X: Pristimerin suppresses colorectal cancer through inhibiting inflammatory responses and Wnt/β-catenin signaling. Toxicol Appl Pharmacol. 386:114813l2020. View Article : Google Scholar |
|
|
Song L, Xu XB and Li ZY: A serine protease extracted from Trichosanthes kirilowii inhibits epithelial-mesenchymal transition via antagonizing PKM2-mediated STAT3/Snail1 pathway in human colorectal adenocarcinoma cells. J Funct Food. 40:639–647. 2018. View Article : Google Scholar |
|
|
Yang P, Liu W, Fu R, Ding GB, Amin S and Li Z: Cucurbitacin E chemosensitizes colorectal cancer cells via mitigating TFAP4/Wnt/β-catenin signaling. J Agric Food Chem. 2020.Epub ahead of print. View Article : Google Scholar |
|
|
Boudreau MD, Mellick PW, Olson GR, Felton RP, Thorn BT and Beland FA: Clear evidence of carcinogenic activity by a whole-leaf extract of Aloe barbadensis miller (Aloe vera) in F344/N rats. Toxicol Sci. 131:26–39. 2013. View Article : Google Scholar : |
|
|
Peng C, Zhang W, Shen X, Yuan Y, Li Y, Zhang W and Yao M: Post-transcriptional regulation activity through alternative splicing involved in the effects of Aloe vera on the Wnt/β-catenin and Notch pathways in colorectal cancer cells. J Pharmacol Sci. 143:148–155. 2020. View Article : Google Scholar : PubMed/NCBI |
|
|
Boudreau MD, Beland FA, Nichols JA and Pogribna M: Toxicology and carcinogenesis studies of a nondecolorized [corrected] whole leaf extract of Aloe barbadensis Miller (Aloe vera) in F344/N rats and B6C3F1 mice (drinking water study). Natl Toxicol Program Tech Rep Ser. 577:1–266. 2013. |
|
|
Yokohira M, Matsuda Y, Suzuki S, Hosokawa K, Yamakawa K, Hashimoto N, Saoo K, Nabae K, Doi Y, Kuno T and Imaida K: Equivocal colonic carcinogenicity of Aloe arborescens miller var natalensis berger at high-dose level in a wistar hannover rat 2-y study. J Food Sci. 74:T24–T30. 2009. View Article : Google Scholar : PubMed/NCBI |
|
|
Peng C, Zhang W, Dai C, Li W, Shen X, Yuan Y, Yan L, Zhang W and Yao M: Study of the aqueous extract of Aloe vera and its two active components on the Wnt/β-catenin and Notch signaling pathways in colorectal cancer cells. J Ethnopharmacol. 243:1120922019. View Article : Google Scholar |
|
|
Dai C, Liu MP, Zhang WJ, Lam CWK, Guo JR, Li W, Wu J, Chen JF, Chen ZG, Zhang W and Yao MC: A material-basis study of Aloe vera on the wnt/beta-catenin signaling pathway using a knockin/knockout method with high-speed countercurrent chromatography. RSC Adv. 7:38819–38829. 2017. View Article : Google Scholar |
|
|
Vinson KE, George DC, Fender AW, Bertrand FE and Sigounas G: The Notch pathway in colorectal cancer. Int J Cancer. 138:1835–1842. 2016. View Article : Google Scholar |
|
|
Zhou ZP, Wang LP, Hong ZS, Qiu CZ, Wang MZ, Chen ZX, Tang LF, Yu WS and Wang CX: Silencing GOLPH3 gene expression reverses resistance to cisplatin in HT29 colon cancer cells via multiple signaling pathways. Int J Oncol. 53:1183–1192. 2018.PubMed/NCBI |
|
|
Wu X, Luo F, Li J, Zhong X and Liu K: Tankyrase 1 inhibitior XAV939 increases chemosensitivity in colon cancer cell lines via inhibition of the Wnt signaling pathway. Int J Oncol. 48:1333–1340. 2016. View Article : Google Scholar : PubMed/NCBI |
|
|
Longley DB, Harkin DP and Johnston PG: 5-fluorouracil: Mechanisms of action and clinical strategies. Nat Rev Cancer. 3:330–338. 2003. View Article : Google Scholar : PubMed/NCBI |
|
|
Yu ZW, Zhao P, Liu M, Dong XS, Tao J, Yao XQ, Yin XH, Li Y and Fu SB: Reversal of 5-flouroucial resistance by adenovirus-mediated transfer of wild-type p53 gene in multidrug-resistant human colon carcinoma LoVo/5-FU cells. World J Gastroenterol. 10:1979–1983. 2004. View Article : Google Scholar : PubMed/NCBI |
|
|
Zhang Z, Zhang Y, Qin X, Wang Y and Fu J: FGF9 promotes cisplatin resistance in colorectal cancer via regulation of Wnt/β-catenin signaling pathway. Exp Ther Med. 19:1711–1718. 2020.PubMed/NCBI |
|
|
Leushacke M, Sporle R, Bernemann C, Brouwer-Lehmitz A, Fritzmann J, Theis M, Buchholz F, Herrmann BG and Morkel M: An RNA interference phenotypic screen identifies a role for FGF signals in colon cancer progression. PLoS One. 6:e233812011. View Article : Google Scholar : PubMed/NCBI |
|
|
Qiu CZ, Wang MZ, Yu WS, Guo YT, Wang CX and Yang XF: Correlation of GOLPH3 gene with Wnt signaling pathway in human colon cancer cells. J Cancer. 7:928–934. 2016. View Article : Google Scholar : PubMed/NCBI |
|
|
Gonçalves JM, Silva CAB, Rivero ERC and Cordeiro MMR: Inhibition of cancer stem cells promoted by Pimozide. Clin Exp Pharmacol Physiol. 46:116–125. 2019. View Article : Google Scholar |
|
|
Rubinstein MR, Wang X, Liu W, Hao Y, Cai G and Han YW: Fusobacterium nucleatum promotes colorectal carcinogenesis by modulating E-cadherin/β-catenin signaling via its FadA adhesin. Cell Host Microbe. 14:195–206. 2013. View Article : Google Scholar : PubMed/NCBI |
|
|
Rubinstein MR, Baik JE, Lagana SM, Han RP, Raab WJ, Sahoo D, Dalerba P, Wang TC and Han YW: Fusobacterium nucleatum promotes colorectal cancer by inducing Wnt/β-catenin modulator Annexin A1. EMBO Rep. 20:e476382019. View Article : Google Scholar |
|
|
Li X, Huang J, Yu T, Fang X, Lou L, Xin S, Ji L, Jiang F and Lou Y: Fusobacterium nucleatum promotes the progression of colorectal cancer through Cdk5-Activated Wnt/β-Catenin Signaling. Front Microbiol. 11:5452512021. View Article : Google Scholar |
|
|
Ghanavati R, Akbari A, Mohammadi F, Asadollahi P, Javadi A, Talebi M and Rohani M: Lactobacillus species inhibitory effect on colorectal cancer progression through modulating the Wnt/β-catenin signaling pathway. Mol Cell Biochem. 470:1–13. 2020. View Article : Google Scholar : PubMed/NCBI |
|
|
Basso K, Saito M, Sumazin P, Margolin AA, Wang K, Lim WK, Kitagawa Y, Schneider C, Alvarez MJ, Califano A and Dalla-Favera R: Integrated biochemical and computational approach identifies BCL6 direct target genes controlling multiple pathways in normal germinal center B cells. Blood. 115:975–984. 2010. View Article : Google Scholar : |
|
|
Cha N, Liu W, Yang N, Xie S, Gao Y, Chen X, Wang X and Ren J: Oncogenicity of LHX4 in colorectal cancer through Wnt/β-catenin/TCF4 cascade. Tumour Biol. 35:10319–10324. 2014. View Article : Google Scholar : PubMed/NCBI |
|
|
Cheng F, Mohanmed MM, Li Z, Zhu L, Zhang Q, Huang Q and Shen W: Capn4 promotes colorectal cancer cell proliferation by increasing MAPK7 through activation of the Wnt/β-Catenin pathway. Exp Cell Res. 363:235–242. 2018. View Article : Google Scholar : PubMed/NCBI |
|
|
Shen J, Yu Z and Li N: The E3 ubiquitin ligase RNF146 promotes colorectal cancer by activating the Wnt/β-catenin pathway via ubiquitination of Axin1. Biochem Biophys Res Commun. 503:991–997. 2018. View Article : Google Scholar : PubMed/NCBI |
|
|
Zhang QW, Zhang XT, Tang CT, Lin XL, Ge ZZ and Li XB: EGFL6 promotes cell proliferation in colorectal cancer via regulation of the WNT/β-catenin pathway. Mol Carcinog. 58:967–979. 2019. View Article : Google Scholar : PubMed/NCBI |
|
|
Zhou C, Li Y, Wang G, Niu W, Zhang J, Wang G, Zhao Q and Fan L: Enhanced SLP-2 promotes invasion and metastasis by regulating Wnt/β-catenin signal pathway in colorectal cancer and predicts poor prognosis. Pathol Res Pract. 215:57–67. 2019. View Article : Google Scholar |
|
|
Mir R, Pradhan SJ, Patil P, Mulherkar R and Galande S: Wnt/β-catenin signaling regulated SATB1 promotes colorectal cancer tumorigenesis and progression. Oncogene. 35:1679–1691. 2016. View Article : Google Scholar |
|
|
Lu W, Fu Z, Wang H, Feng J, Wei J and Guo J: Peroxiredoxin 2 knockdown by RNA interference inhibits the growth of colorectal cancer cells by downregulating Wnt/β-catenin signaling. Cancer Lett. 343:190–199. 2014. View Article : Google Scholar |
|
|
Koo BK, Spit M, Jordens I, Low TY, Stange DE, van deWetering M, van Es JH, Mohammed S, Heck AJ, Maurice MM and Clevers H: Tumour suppressor RNF43 is a stem-cell E3 ligase that induces endocytosis of Wnt receptors. Nature. 488:665–669. 2012. View Article : Google Scholar : PubMed/NCBI |
|
|
Jiang X, Charlat O, Zamponi R, Yang Y and Cong F: Dishevelled promotes Wnt receptor degradation through recruitment of ZNRF3/RNF43 E3 ubiquitin ligases. Mol Cell. 58:522–533. 2015. View Article : Google Scholar : PubMed/NCBI |
|
|
Guo Q, Wu M, Lian P, Liao M, Xiao Z, Wang X and Shen S: Synergistic effect of indomethacin and NGX6 on proliferation and invasion by human colorectal cancer cells through modulation of the Wnt/beta-catenin signaling pathway. Mol Cell Biochem. 330:71–81. 2009. View Article : Google Scholar : PubMed/NCBI |
|
|
Lee JH, Bae JA, Lee JH, Seo YW, Kho DH, Sun EG, Lee SE, Cho SH, Joo YE, Ahn KY, et al: Glycoprotein 90K, downregulated in advanced colorectal cancer tissues, interacts with CD9/CD82 and suppresses the Wnt/beta-catenin signal via ISGylation of beta-catenin. Gut. 59:907–917. 2010. View Article : Google Scholar : PubMed/NCBI |
|
|
Tong X, Zhuang Z, Wang X, Yang X, Bai L, Su L, Wei P and Su X: ACBP suppresses the proliferation, migration, and invasion of colorectal cancer via targeting Wnt/beta-catenin signaling pathway. Biomed Pharmacother. 137:1112092021. View Article : Google Scholar : PubMed/NCBI |
|
|
Meng WJ, Yan H, Li Y and Zhou ZG: SATB1 and colorectal cancer in Wnt/β-catenin signaling: Is there a functional link? Med Hypotheses. 76:277–279. 2011. View Article : Google Scholar |
|
|
Gou H, Liang JQ, Zhang L, Chen H, Zhang Y, Li R, Wang X, Ji J, Tong JH, To KF, et al: TTPAL promotes colorectal tumorigenesis by stabilizing TRIP6 to activate Wnt/β-catenin signaling. Cancer Res. 79:3332–3346. 2019. View Article : Google Scholar : PubMed/NCBI |
|
|
Jiang S, Song C, Gu X, Wang M, Miao D, Lv J and Liu Y: Ubiquitin-specific peptidase 22 contributes to colorectal cancer stemness and chemoresistance via Wnt/β-Catenin pathway. Cell Physiol Biochem. 46:1412–1422. 2018. View Article : Google Scholar |
|
|
Jiang S, Miao D, Wang M, Lv J, Wang Y and Tong J: MiR-30-5p suppresses cell chemoresistance and stemness in colorectal cancer through USP22/Wnt/β-catenin signaling axis. J Cell Mol Med. 23:630–640. 2019. View Article : Google Scholar |
|
|
Huang T, Zhang Q, Ren W, Yan B, Yi L, Tang T, Lin H and Zhang Y: USP44 suppresses proliferation and enhances apoptosis in colorectal cancer cells by inactivating the Wnt/β-catenin pathway via Axin1 deubiquitination. Cell Biol Int. 44:1651–1659. 2020. View Article : Google Scholar : PubMed/NCBI |
|
|
Ohsugi T, Yamaguchi K, Zhu C, Ikenoue T, Takane K, Shinozaki M, Tsurita G, Yano H and Furukawa Y: Anti-apoptotic effect by the suppression of IRF1 as a downstream of Wnt/β-catenin signaling in colorectal cancer cells. Oncogene. 38:6051–6064. 2019. View Article : Google Scholar : PubMed/NCBI |
|
|
Ohsugi T, Yamaguchi K, Zhu C, Ikenoue T and Furukawa Y: Decreased expression of interferon-induced protein 2 (IFIT2) by Wnt/beta-catenin signaling confers anti-apoptotic properties to colorectal cancer cells. Oncotarget. 8:100176–100186. 2017. View Article : Google Scholar : PubMed/NCBI |
